143 related articles for article (PubMed ID: 19112825)
1. [TGF beta signalling accessory receptors].
Mokrosiński J; Krajewska WM
Postepy Biochem; 2008; 54(3):264-73. PubMed ID: 19112825
[TBL] [Abstract][Full Text] [Related]
2. Endoglin expression on human microvascular endothelial cells association with betaglycan and formation of higher order complexes with TGF-beta signalling receptors.
Wong SH; Hamel L; Chevalier S; Philip A
Eur J Biochem; 2000 Sep; 267(17):5550-60. PubMed ID: 10951214
[TBL] [Abstract][Full Text] [Related]
3. TGF-β and its coreceptors in cancerogenesis: an overview.
Todorović-Raković N; Milovanović J; Nikolić-Vukosavljević D
Biomark Med; 2011 Dec; 5(6):855-63. PubMed ID: 22103622
[TBL] [Abstract][Full Text] [Related]
4. CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis.
Litvinov IV; Bizet AA; Binamer Y; Jones DA; Sasseville D; Philip A
Exp Dermatol; 2011 Aug; 20(8):627-32. PubMed ID: 21539622
[TBL] [Abstract][Full Text] [Related]
5. The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors.
Bizet AA; Liu K; Tran-Khanh N; Saksena A; Vorstenbosch J; Finnson KW; Buschmann MD; Philip A
Biochim Biophys Acta; 2011 May; 1813(5):742-53. PubMed ID: 21295082
[TBL] [Abstract][Full Text] [Related]
6. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
[TBL] [Abstract][Full Text] [Related]
7. Identification of endoglin in rat hepatic stellate cells: new insights into transforming growth factor beta receptor signaling.
Meurer SK; Tihaa L; Lahme B; Gressner AM; Weiskirchen R
J Biol Chem; 2005 Jan; 280(4):3078-87. PubMed ID: 15537649
[TBL] [Abstract][Full Text] [Related]
8. Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan.
Letamendía A; Lastres P; Botella LM; Raab U; Langa C; Velasco B; Attisano L; Bernabeu C
J Biol Chem; 1998 Dec; 273(49):33011-9. PubMed ID: 9830054
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD109 binds TGF-β and antagonizes TGF-β signalling and responses.
Li C; Hancock MA; Sehgal P; Zhou S; Reinhardt DP; Philip A
Biochem J; 2016 Mar; 473(5):537-47. PubMed ID: 26621871
[TBL] [Abstract][Full Text] [Related]
10. Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells.
Zhang H; Shaw AR; Mak A; Letarte M
J Immunol; 1996 Jan; 156(2):564-73. PubMed ID: 8543807
[TBL] [Abstract][Full Text] [Related]
11. Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway.
Santander C; Brandan E
Cell Signal; 2006 Sep; 18(9):1482-91. PubMed ID: 16413747
[TBL] [Abstract][Full Text] [Related]
12. Endoglin is expressed on human chondrocytes and forms a heteromeric complex with betaglycan in a ligand and type II TGFbeta receptor independent manner.
Parker WL; Goldring MB; Philip A
J Bone Miner Res; 2003 Feb; 18(2):289-302. PubMed ID: 12568406
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan.
Farnworth PG; Wang Y; Escalona R; Leembruggen P; Ooi GT; Findlay JK
Endocrinology; 2007 Nov; 148(11):5355-68. PubMed ID: 17656464
[TBL] [Abstract][Full Text] [Related]
14. Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites.
López-Casillas F; Payne HM; Andres JL; Massagué J
J Cell Biol; 1994 Feb; 124(4):557-68. PubMed ID: 8106553
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta receptor signaling.
Derynck R; Feng XH
Biochim Biophys Acta; 1997 Oct; 1333(2):F105-50. PubMed ID: 9395284
[No Abstract] [Full Text] [Related]
16. Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A.
Esparza-Lopez J; Montiel JL; Vilchis-Landeros MM; Okadome T; Miyazono K; López-Casillas F
J Biol Chem; 2001 May; 276(18):14588-96. PubMed ID: 11278442
[TBL] [Abstract][Full Text] [Related]
17. Expression of transforming growth factor beta and transforming growth factor beta receptors on AIDS-associated Kaposi's sarcoma.
Ciernik IF; Krayenbühl Ciernik BH; Cockerell CJ; Minna JD; Gazdar AF; Carbone DP
Clin Cancer Res; 1995 Oct; 1(10):1119-24. PubMed ID: 9815902
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic control of TGF-β co-receptor activity by BMP-1/tolloid-like proteases revealed by quantitative iTRAQ proteomics.
Delolme F; Anastasi C; Alcaraz LB; Mendoza V; Vadon-Le Goff S; Talantikite M; Capomaccio R; Mevaere J; Fortin L; Mazzocut D; Damour O; Zanella-Cléon I; Hulmes DJ; Overall CM; Valcourt U; Lopez-Casillas F; Moali C
Cell Mol Life Sci; 2015 Mar; 72(5):1009-27. PubMed ID: 25260970
[TBL] [Abstract][Full Text] [Related]
19. Structural biology of betaglycan and endoglin, membrane-bound co-receptors of the TGF-beta family.
Kim SK; Henen MA; Hinck AP
Exp Biol Med (Maywood); 2019 Dec; 244(17):1547-1558. PubMed ID: 31601110
[TBL] [Abstract][Full Text] [Related]
20. TGF-{beta} signaling of human T cells is modulated by the ancillary TGF-{beta} receptor endoglin.
Schmidt-Weber CB; Letarte M; Kunzmann S; Rückert B; Bernabéu C; Blaser K
Int Immunol; 2005 Jul; 17(7):921-30. PubMed ID: 15967783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
